Systematic Identification of Methyllysine-Driven Interactions for Histone and Nonhistone Targets
Liu, Huadong, Galka, Marek, Iberg, Aimee, Wang, Zezhou, Li, Lei, Voss, Courtney, Jiang, Xinfeng, Lajoie, Gilles, Huang, Zhiping, Bedford, Mark T, Li, Shawn S. C
Published in Journal of proteome research (05.11.2010)
Published in Journal of proteome research (05.11.2010)
Get full text
Journal Article
Increased thymus- and decreased parathyroid-fated organ domains in Splotch mutant embryos
Griffith, Ann V., Cardenas, Kim, Carter, Carla, Gordon, Julie, Iberg, Aimee, Engleka, Kurt, Epstein, Jonathan A., Manley, Nancy R., Richie, Ellen R.
Published in Developmental biology (01.03.2009)
Published in Developmental biology (01.03.2009)
Get full text
Journal Article
Design and evaluation of a restraint-free small animal inhalation dosing chamber
McConville, Jason T, Williams, 3rd, Robert O, Carvalho, Thiago C, Iberg, Aimee N, Johnston, Keith P, Talbert, Robert L, Burgess, David, Peters, Jay I
Published in Drug development and industrial pharmacy (01.01.2005)
Published in Drug development and industrial pharmacy (01.01.2005)
Get more information
Journal Article
Abstract 1627: Preclinical characterization of a novel CTLA-4-targeted ETB for direct Treg depletion
Khanna, Swati, Howard, Caleigh, Rabia, Lilia A., Aldana, Alvaro, Zhao, Jay, Chang, Betty, Ramos, Hilario J., Iberg, Aimee
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract P1-18-35: MT-5111, a novel HER2 targeting engineered toxin body, under clinical development to overcome mechanisms of resistance to existing HER2 targeted therapies
Higgins, Jack P, Sarkar, Asis, Williams, Eric T, Iberg, Aimee, Waltzman, Roger, Willert, Erin K
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Abstract 539: Novel engineered toxin bodies targeting SLAMF7 (CS1)
Iberg, Aimee, Cornelison, Garrett L., Howard, Caleigh, Robinson, Garrett L., Zhao, Jay, Ramos, Hilario J., Willert, Erin K.
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
WNT signalling control by KDM5C during development affects cognition
Karwacki-Neisius, Violetta, Jang, Ahram, Cukuroglu, Engin, Tai, Albert, Jiao, Alan, Predes, Danilo, Yoon, Joon, Brookes, Emily, Chen, Jiekai, Iberg, Aimee, Halbritter, Florian, Õunap, Katrin, Gecz, Jozef, Schlaeger, Thorsten M., Ho Sui, Shannan, Göke, Jonathan, He, Xi, Lehtinen, Maria K., Pomeroy, Scott L., Shi, Yang
Published in Nature (London) (21.03.2024)
Published in Nature (London) (21.03.2024)
Get full text
Journal Article
MT-5111: A novel HER2 targeting engineered toxin body in clinical development
Waltzman, Roger J., Sarkar, Asis, Williams, Eric T, Iberg, Aimee T., Higgins, Jack T., Willert, Erin K.
Published in Journal of clinical oncology (01.02.2020)
Published in Journal of clinical oncology (01.02.2020)
Get full text
Journal Article
Abstract 2984: Design and characterization of bispecific engineered toxin bodies for targeted cancer therapy
Iberg, Aimee, Cornelison, Garrett L., Howard, Caleigh, Amador, Paul, Rivera, Steven, Jamaleddine, Michael, Robinson, Garrett L., Willert, Erin K.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract 521: CD45 targeted engineered toxin bodies deplete hematopoietic and malignant cells
Iberg, Aimee, Robinson, Garrett L., LeMar, Sara, Dekker, Joseph D., Zhao, Jay, Ramos, Hilario J., Singh, Melissa M., Willert, Erin K.
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract 2278: CTLA-4 targeted engineered toxin bodies designed to deplete regulatory T cells (Tregs)
Iberg, Aimee, Acquaye-Seedah, Edith, Rabia, Lilia A., Robinson, Garrett L., Ramos, Hilario J., Dekker, Joseph D., Zhao, Jay, Willert, Erin K.
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
PD-L1 targeted engineered toxin body provides direct cytotoxicity and T-cell mediated tumor targeting
Waltzman, Roger J., Brieschke, Brigitte, LeMar, Sara, Dekker, Joseph, Cornelison, Garrett, Robinson, Garrett L., Sarkar, Asis, Zhao, Jay, Iberg, Aimee T., Ramos, Hilario J., Willert, Erin K.
Published in Journal of clinical oncology (10.02.2020)
Published in Journal of clinical oncology (10.02.2020)
Get full text
Journal Article
Lung-Resident Mesenchymal Stromal Cells Reveal Transcriptional Dynamics of Lung Development in Preterm Infants
Spadafora, Ruggero, Lu, Junjie, Khetani, Radhika S, Zhang, Cheng, Iberg, Aimee, Li, Hu, Shi, Yang, Lerou, Paul H
Published in American journal of respiratory and critical care medicine (01.10.2018)
Published in American journal of respiratory and critical care medicine (01.10.2018)
Get full text
Journal Article
Engineered Toxin Bodies delivering immunogenic MHC class I peptides to tumor cells summon polyfunctional and relevant CTL responses against cancers
Dekker, Joseph D, Brieschke, Brigitte, LeMar, Sara, Cornelison, Garrett L., Iberg, Aimee, Robinson, Garrett L., Chu, Shaoyou, Willert, Erin K, Ramos, Hilario J.
Published in The Journal of immunology (1950) (01.05.2019)
Published in The Journal of immunology (1950) (01.05.2019)
Get full text
Journal Article
Abstract 3366: In vivo efficacy of a PD-L1 targeted, antigen seeding engineered toxin body
Ramos, Hilario J., Brieschke, Brigitte, LeMar, Sara, Dekker, Joseph D., Iberg, Aimee, Robinson, Garrett L., Sarkar, Asis, Anand, Banmeet, Singh, Melissa M., Zhao, Jay, Higgins, Jack P., Willert, Erin K.
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract 3900: The Safety and efficacy profile of a PD-L1 directed, Engineered Toxin Body, as a novel targeted direct-cell kill approach for the treatment of PD-L1 expressing cancers
Ramos, Hilario J., Sarkar, Asis K., Mar, Sara Le, Brieschke, Brigitte, Dekker, Joseph D., Partridge, Veronica R., Maceda, Pablo A., Sousares, Michaela M., Robinson, Garrett L., Iberg, Aimee, Chu, Shaoyou, Liu, Jensing, Higgins, Jack P., Willert, Erin K.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract 335: c-KIT targeted ETBs for cancer therapy and HSC transplant conditioning
Howard, Caleigh, Wiley, Shu, Dong, Wenzhao, Mendiola, Andrea, Partridge, Veronica, LeMar, Sara, Amador, Paul, Chaudhary, Amit K., Dekker, Joseph D., Zhao, Jay, Durland, Ross, Iberg, Aimee
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract 3538: A CTLA-4 targeted ETB for Treg depletion shows favorable preclinical efficacy and safety
Sarkar, Asis, Martin, Rebecca, Byrne, Lauren R., Howard, Caleigh, Khanna, Swati, Rabia, Lilia A., Adhikari, Diana, Sousares, Michaela M., Aldana, Alvaro, Robinson, Garrett L., Zhao, Jay, Moore, Chris B., Iberg, Aimee
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article